Print
|
Close
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Active:
No
Cancer Type:
Breast Cancer
NCT ID:
NCT04188548
Trial Phases:
Phase I
Protocol IDs:
17502 (primary)
2019-003581-41
J2J-MC-JZLA
NCI-2020-06404
Eligibility:
18 Years and older, Male and Female
Study Type:
Treatment
Study Sponsor:
Eli Lilly and Company
NCI Full Details:
http://clinicaltrials.gov/show/NCT04188548
Summary
The reason for this study is to see if the study drug LY3484356 alone or in combination with
other anticancer therapies is safe and effective in participants with advanced or metastatic
breast cancer or endometrial cancer.
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts...
Click here to learn more about clinical trials
.